ribociclib
novartis
['bcsm', 'natalee', ' ribo']
natalee showed that adjuvant ribo (400 mg)/nsai for 3 years -improved in idfs and ddsf and led to a numerical benefit os in patient with intermmediate and high risk disease #asco23 #bcsm 
Breast medical oncologist @TuftsMedicalCtr | Tweets are my own and not medical advice | 🇲🇽